Medical/Pharmaceuticals

RBC Expands Global Youth Charity Program - RBC Charity Day for the Kids

* Virtual celebrations held by RBC Capital Markets employees in Canada, U.S., U.K.,France, Germany, Japan, Hong Kong, Australia, Barbados and Bahamas * US$5 million donated to over 50 charities worldwide SYDNEY, June 18, 2021 /PRNewswire/ -- As part of a global charitable initiative called RBC...

2021-06-17 20:00 2262

Envirotainer Announces Cathay Pacific as First Asian carrier for the recently released Releye® RLP container

STOCKHOLM, June 17, 2021 /PRNewswire/ -- Envirotainer, the global market leader in secure cold chain solutions for air transportation of pharmaceuticals, today announced that Cathay Pacific has approved the Envirotainer Releye® RLP for carriage on its fleet of aircraft. Cathay Pacific can now off...

2021-06-17 19:49 1889

Eccogene announces the addition of Jacques Mizrahi, PhD to Scientific Advisory Board

SHANGHAI, June 17, 2021 /PRNewswire/ -- Eccogene, Inc., a clinical stage biopharmaceutical company focused on discovery and development of metabolic and immunologic therapeutics, announced today the addition ofJacques Mizrahi, Ph.D., to its scientific advisory board.

2021-06-17 19:49 2996

Harbour BioMed Announces Dosing of First Patient of Next-Generation Anti-CTLA-4 Antibody in Combination with PD-1 Antibody in Patients with NSCLC

CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SUZHOU, China, June 17, 2021 /PRNewswire/ -- Harbour BioMed ("HBM", HKEX: 02142) today announced the dosing of the first patient of HBM4003 in patients with advanced non-small cell lung cancer in its open phase I clinical study. This study will eval...

2021-06-17 15:41 14361

Elekta radiotherapy system designed for changing cancer landscape now available for U.S. patients

ATLANTA, June 17, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that its Elekta Harmony* radiation therapy system recently received U.S. FDA 510(k) clearance, paving the way for U.S. clinics to harness the system to treat a comprehensive range of indications using the latest radiotherap...

2021-06-17 14:38 15833

Cigna Survey Confirms Mental Health Services and Support Critical to Global Pandemic Recovery

* Markets with higher COVID-19 vaccination rates report better outlook on health and well-being * Mental health seen as most important influence of whole person health, virtual mental health consultations increased 89 percent since beginning of pandemic * Employees expect more from employer...

2021-06-17 11:38 15559

InnoCare Announces Orphan Drug Designation of Gunagrabtinib by US FDA for Treatment of Cholangiocarcinoma

BEIJING, June 16, 2021 /PRNewswire/ -- InnoCare (HKEX: 09969), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, announced today that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to its pan-FGFR inhibitor gunagratinib (ICP-192) ...

2021-06-17 11:31 14637

BitePRO Clothing Aims to Reduce Control and Restraint in Mental Health Care

WETHERBY, England, June 16, 2021 /PRNewswire/ -- According to protective clothing manufacturer,BitePRO , specifically designed protective clothing for health care professionals, as well as patients and service users, will help reduce the use of force within mental health...

2021-06-16 23:07 3619

Gannex Announces Positive Topline Results of the U.S. Phase I Trial of NASH Drug ASC42, an FXR Agonist

SHANGHAI, June 16, 2021 /PRNewswire/ -- Gannex, a wholly owned company of Ascletis Pharma Inc. (HKEX: 1672), fully dedicated to the R&D and commercialization of new drugs in the field of non-alcoholic steatohepatitis (NASH), today announces positive topline results of safety and pharmacodynamic ...

2021-06-16 21:00 3788

Spark Aligners Does It Again With Market Leading Innovation And New FDA Approval To Give Doctors Greater Control And Flexibility

-- New Features in Release 11 Combined with Expanded Indication for Mixed Dentition  to Treat Kids and Teens is a Home Run for Doctors -- BREA, Calif., June 16, 2021 /PRNewswire/ -- Ormco Corporation, a global leader of orthodontic solutions, today announced it has received FDA clearance to tre...

2021-06-16 20:45 1902

Clarivate Report Demonstrates that Nations or Institutions with Diverse Research Priorities Respond More Comprehensively to Unprecedented Scientific Challenges

Forward-looking approach offers a valuable new tool for anticipating and preparing for the unexpected LONDON, June 16, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today released a new Global ...

2021-06-16 15:00 9383

Harbour BioMed and Dana-Farber Cancer Institute Collaborate to Advance Novel Biotherapies for Cancer Treatment

CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SUZHOU, China, June 15, 2021 /PRNewswire/ -- Harbour BioMed (HKEX: 02142) announced today it has entered into a multi-year, multifaceted research collaboration agreement with Dana-Farber Cancer Institute to co-develop novel biotherapies in cancer t...

2021-06-16 13:08 8933

Carepool Asia - Malaysia's first multi-disciplinary digital healthcare platform that offers unlimited telehealth appointments

KUALA LUMPUR, Malaysia, June 16, 2021 /PRNewswire/ -- CAREPOOL ASIA, an innovative digital health platform launches its new, affordable digital health packages, the first telehealth platform that offers unlimited consultation services via a monthly subscription fee, as low asRM170 per month for t...

2021-06-16 12:35 2997

Medidata Becomes First Company to Offer End-to-End, Unified, Secure Platform for Decentralization of Clinical Trials (DCT)

* The first company in the world to unify direct patient data capture technology with study oversight and monitoring, Medidata redefines end-to-end decentralization for sponsors and CROs * The unique Medidata Trial Dial™ concept provides the industry's highest level of customization for c...

2021-06-16 09:11 3286

 Smith+Nephew launches Real Intelligence and CORI™ Surgical System, next generation robotics platform, in Australia and New Zealand

LONDON, June 16, 2021 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces the launch of its Real Intelligence suite of enabling technology solutions including its next generation robotics platform, the CORI Surgical System, inAustralia and New ...

2021-06-16 06:00 12800

Galimedix Accelerating Development of Its Next-Generation Oral Anti-Amyloid Beta Drug GAL-201 for Alzheimer's Disease

Following recent FDA approval of Biogen's Alzheimer antibody drug ADUHELM (TM), targeting oligomers of amyloid beta, Galimedix aims for first patients with its GAL-201 oral small molecule drug within one year. KENSINGTON, Md., June 16, 2021 /PRNewswire/ -- Galimedix, Inc., a clinical-stage bioph...

2021-06-16 04:38 1249

VNTC confirms Dong-A ST its sole distributor of scoliosis brace Spinamic in South Korea

SEOUL, South Korea, June 15, 2021 /PRNewswire/ -- VNTC, a MedTech company, announced onJune 15 its signing of a Korean distributorship contract with Dong-A ST. The two companies are now able to provide a wide range of services both at home and abroad through mutual cooperation in sales and market...

2021-06-16 00:00 3582

Frontera Therapeutics Starts GMP Manufacturing Facility Construction

SUZHOU, China, June 15, 2021 /PRNewswire/ -- On June 9, 2021, Frontera Therapeutics Co., Ltd. ('Frontera') held a groundbreaking ceremony to start the construction of its Suzhou facility in bioBAY of Suzhou Industrial Park (SIP), Jiangsu, China. President of Suzhou Frontera, Dr. Xinyan Li, hosted ...

2021-06-15 23:32 2084

BIO Digital Taiwan Day will be held on June 22

TAIPEI, June 15, 2021 /PRNewswire/ -- With COVID-19 dramatically changing the healthcare industry, organizations have been forced to adapt their practices and embrace digital transformation - and now, as vaccines become more available in the developed countries, it is time to look into the future...

2021-06-15 23:00 2673

Kazia Enters Clinical Collaboration With Cornell University for Phase II Clinical Study Using Paxalisib in Combination With Ketogenic Diet for Glioblastoma

SYDNEY, June 15, 2021 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce that it has entered a collaboration with theJoan & Sanford I Weill Medical College of Cornell University in the United States, to launch ...

2021-06-15 22:00 11548
1 ... 602603604605606607608 ... 645

Week's Top Stories